[Seite 15↓]

Literatur

Aihara H, Miyazaki JI (1998). Gene transfer into muscle by electroporation in vivo. Nature Biotechnol. 16: 867 - 870.

Alvarez RD, Curiel DT (1997) A phase I study of recombinant adenovirus vector-mediatedintraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-tk) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients. Hum. Gene Ther. 8: 597 - 613.

Anderson WF (1992) Human gene therapy. Science 256: 808 - 813.

Bishop JM (1991) Molecular themes in oncogenesis. Cell 64: 235 - 248.

Blackburn RV, Galoforo S, Corry PM, Lee YJ (1998) Adenoviral mediated transfer of a heat inducible double suicides gene into prostate carcinoma. Cancer Res. 58: 1358 - 1362.

Chang EH, Pirollo KF, Bouker KB (2000) Tp53 gene therapy: a key to modulating resistance to anticancer therapies? Mol. Med. Today 6: 358 - 364.

Chin KV, Tanaka S, Darlington G, Pastan I, Gottesmann MM (1990) Heat shock and asenite increase expression of the multidrug resistance gene in human renal carcinoma cells. J. Biol. Chem. 265: 221 - 226.

Furth PA, Kerr D, Wall R (1995) Gene transfer by jet injection into differentiated tissues of living animals and in organ culture. Mol. Biotechnol. 4: 121 - 127.

Furth PA, Shamay A, Wall RJ, Henninghausen L (1992) Gene tansfer into somatic tissues by jet injection. Anal. Biochem. 205: 365 - 368.

Gewirtz A, Sokol DL, Ratajczak M (1998) Nucleic acid therapeutics: state of the art and future prospects. Blood 92: 712 - 736.

Habib NA, Ding SF, El-Masry R, Mitry RR, Honda K, Michail NE, Della Serra G, Izzi G, Greco L, Bossyouni M, El-Toukhy M, Abdel-Ghaffar Y (1996) Preliminary report: the short term effects of direct p53 DNA injection in primary hepatocellular carcinomas. Cancer Detect. & Preven. 20: 103 - 107.

Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Hellman S, Kufe DW, Weichselbaum RR (1995) Spatial and temporal control of gene therapy using ionizing radiation. Gene Ther. 1: 170 - 175.

Heller L, Jaroszesky MJ, Coppola D, Pottinger C, Gilbert R, Heller R (2000) Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther. 7: 826 - 829.

Huang Q, Hu JK, Lohr F, Zhang L, Braun R, Lanzen J, Little JB, Dewhirst MW, Li CY (2000) Heat- induced gene expression as a novel targeted cancer therapy strategy. Cancer Res. 60: 3435 - 3439.

Kerr DE, Furth PA, Powell RJ, Wall RJ (1996) Expression of gene-gun injected plasmid DNA in the ovine mammary gland and in lymph nodes draining the injection site. Animal Biotechnol. 7: 33 - 45.


[Seite 16↓]

Kijima H, Ishida H, Ohkawa T, Kashani-Sabet M, Scanlon KJ (1995) Therapeutic applications of ribozymes. Pharmacol. Ther. 68: 247 - 267.

Klostergaard J, Leroux ME, Hsu HA, Hsi BP, Siddik ZH, Danhauser LL, Tomasovi SP (1996) Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro. Cancer Chemother. Pharmacol. 37: 235 - 237.

Kohno K, Sato S, Takano H, Matsuo K, Kuwano M (1989). The direct activation of human multidrug resistance gene (mdr1) by anticancer agents. Biochem. Biophys. Res. Comm. 165: 1415 - 1421.

Li S, Huang L (2000) Nonviral gene therapy: promises ans challanges. Gene Ther. 7: 31 - 34.

Lin JC, Park HJ, Song CW (1996) Combined treatment of IL-1 alpha and TNF-alpha potentiates the antitumor effects of hyperthermia. Int. J. Hyperthermia 12: 335 - 344.

Luger S (2000) c-myb antisense oligonucleotide therapeutics for hematologic malignancies. In: Walther W, Stein U, editors. Gene Therapy of Cancer: Methods and Protocols. 1st ed. Totowa, NJ; Humana Press; pp.: 577 - 592.

Luna MC, Ferrario A, Wong S, Fisher A M, Gomer CJ (2000) Photodynamic therapy-mediated oxydative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter. Cancer Res. 60: 1637 - 1644.

Mölling K (1997). Naked DNA for vaccine or therapy J. Mol. Med. 75: 242 - 246.

Mullen CA, Kilstrup M, Blease M (1992) Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA 89: 33 - 37.

Nettelbeck DM, Jerome V, Müller R (2000) Designer promoters for tumor targeting. Trends Genet. 16: 174 - 181.

Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther. 9: 1647 - 1652.

Nishi T, Yoshizato K, Yamashiro S, Takeshima H, Sato K, Hamada K, Kitamura I, Yoshimura T, Saya H, Kuratsu JI, Ushio Y (1996) High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res. 56: 1050 - 1055.

O'Dwyer PJ, Stevenson JP, Gallagher M, Cassella A, Vasilevskaya I, Monia BP, Holmlund J, Dorr FA, Yao KS (1999) c-raf-1 depletion and tumor responses in patients treated with the c-raf-1 antisense oligodeoxynucleotide ISIS 5132 (CGP 69846A). Clin. Cancer Res. 5: 3977 - 3982.

Piche A, Rancourt C (2001) Gene therapy to overcome drug resistance in cancer: targeting key regulators of the apoptotic pathway. Curr. Gene Ther. 1: 317 – 324

Pope IM, Poston GJ, Kinsella AR (1997) The role of the bystander effect in suicide gene therapy. Eur. J. Cancer 33: 1005 - 1016.


[Seite 17↓]

Rackmilevich AL, Turner J, Ford MJ, McCabe D, Sun WH, Sondel PM, Grota K, Yang NS (1996) Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc. Natl. Acad Sci. 93: 6291 - 6296.

Roth JA (1996) Clinical protocol: modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expression wild-type p53 and cisplatin. Hum. Gene Ther. 7: 1013 - 1030.

Roth JA et al. (1996) Retrovirus-mediated wild-type p53 gene transfer to tumor of patients with lung cancer. Nat. Medicine 2: 985 - 991.

Roth JA, Swisher SG, Meyn RE (1999) p53 tumor suppressor gene therapy of cancer. Oncology 13: 148 - 154.

Stein U, Jürchott K, Walther W, Bergmann S, Schlag PM, Royer H-D (2001) Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters. J. Biol. Chem. 276: 28562 - 28569.

Stein U, Walther W, Shoemaker RH (1996) Vincristine induction of mutant and wild type human multidrug-resistance promoters is dose-dependent and cell type specific. J. Cancer Res. Clin. Oncol. 122: 275 - 282.

Sun Y, Jurgovsky K, Moller P, Alijagic S, Dorbic T, Georgieva J, Wittig B, Schadendorf D (1998) Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study. Hum. Gene Ther. 5: 481 - 490.

Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB Jr, Richli WR, Savin M, Waugh MK et al. (1999) Adenovirus-mediatedp53 gene transfer in advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 91: 763 - 771.

Uchiumi T, Kohno K, Tanimura H, Hidaka K, Asakuno K, Abe H, Uchida Y, Kuwano M (1993) Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter. FEBS Lett. 326: 11 - 16.

Vahlsing HL, Yankauckas MA, Sawdey M, Gromkowski SH, Manthorpe M (1994) Immunization with plasmid DNA using a pneumatic gun. J. Immunol. Methods 175: 11-22.

Walther W, Stein U (2000) Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 60: 249-271.

Walther W, Stein U, Fichtner I, Alexander M, Shoemaker RH, Schlag PM (2000) mdr1 promoter driven TNFα-expression for a chemotherapy-controllable combined in vivo gene- and chemotherapy of tumors. Cancer Gene Ther. 7: 893 - 900.

Walther W, Stein U, Schlag PM (2002) Use of the human mdr1 promoter for heat-inducible expression of therapeutic genes. Int. J. Cancer 98: 291 - 296.


[Seite 18↓]

Webb A, Cunningham D, Cotter F, Clarke PA, di Stefano F, Ross P, Corbo M, Dziewanowska Z. (1997) BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 349: 1137 - 1141.

Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465 - 1468.

Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D (1990) In vivo and in vitro gene transfer to mammalian cells by particle bombardment. Proc. Natl. Acad. Sci. 87: 9568 - 9572.

Zhang G, Song YK, Liu D (2000) Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure. Gene Ther. 7: 1344 - 1349.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
24.05.2004